Abstract：Reversing multidrug resistance in leukemia is challenging. Studies have shown that PTEN gene is a tumor suppressor gene with protein phosphatase and lipid phosphatase activities. PTEN gene participates in cell growth, differentiation and proliferation through various signalling pathways and leukemia stem cells (LSCs) show mutation, deletion or reduction in expression of the PTEN gene. As such, PTEN gene is a potential target for clearing LSCs and reversing multidrug resistance in leukemia. This paper analyzes the regulatory activity of PTEN gene on cell growth, differentiation and proliferation through inhibiting the MAPK, FAK/P130cas and PI3K/AKt/mToR signalling pathways, also reviews the recent advancements in the research on the role of PTEN gene in multidrug resistance in leukemia.
林楠 吕鹏 赵欢 吴朝旭 王寅 曾志豪 侯丽 张雅月. 白血病多药耐药与PTEN调控作用的研究进展[J]. 中国医药导报, 2019, 16(15): 48-51.
LIN Nan LYU Peng ZHAO Huan WU Chaoxu WANG Yin ZENG Zhihao HOU Li ZHANG Yayue. Research progress on multidrug resistance in leukemia and regulation of PTEN. 中国医药导报, 2019, 16(15): 48-51.
[1] Huang M，Inukai T，Miyake K，et al. Clofarabine exerts antileukemic activity against cytarabine-resistant B-cell precursor acute lymphoblastic leukemia with low deoxycytidine kinase expression [J]. Cancer Med，2018，7（4）：1297-1316.
[2] Arrigoni E，Del RM，Galimberti S，et al. Concise Review：Chronic Myeloid Leukemia：Stem Cell Niche and Response to Pharmacologic Treatment [J]. Stem Cells Transl Med， 2018，7（3）：305-314.
[3] Xu L，Wu H，Wu X，et al. The expression pattern of Bcl11a，Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia [J]. Asia Pac J Clin Oncol，2017，11（2）：116-119.
[4] Zayed RA，Eltaweel MA，Botros K，et al. MN1 and PTEN gene expression in acute myeloid leukemia [J]. Cancer Biomark，2017，18（2）：177-182.
[5] Yndestad S，Austreid E，Knappskog S，et al. High PTEN gene expression is a negative prognostic marker in human primary breast cancers with preserved p53 function [J]. Breast Cancer Res Treat，2017，163（1）：177-190.
[6] Cheong JW，Eom JI，Maeng HY，et al. Phosphatase and tensin homologue phosphorylation in the C-terminal regulatory domain is frequently observed in acute myeloid leukaemia and associated with poor clinical outcome [J]. Br J Haematol，2003，122（3）：454-456.
[7] Wang LL，Hao S，Zhang S，et al. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases [J]. Hum Pathol，2017，61：49-57.
[8] Mohammadi S，Ghaffari SH，Shaiegan M，et al. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/beta-catenin pathways in AML cells [J]. Life Sci，2016，152：190-198.
[9] Jaraiz-Rodriguez M，Tabernero MD，Gonzalez-Tablas M，et al. A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration，Invasion，and Survival through Src，PTEN，and FAK [J]. Stem Cell Reports，2017，9（2）：451-463.
[10] Pan H，Lu L，Wang X，et al. Gambogic Acid Induces Cell Apoptosis and Inhibits MAPK Pathway in PTEN（-/-）/p53（-/-）Prostate Cancer Cells In Vitro and Ex Vivo [J]. Chin J Integr Med，2018，24（2）：109-116.
[11] Zayed RA，Eltaweel MA，Botros SK，et al. MN1 and PTEN gene expression in acute myeloid leukemia [J]. Cancer Biomark，2017，18（2）：177-182.
[12] Roman-Gomez J，Jimenez-Velasco A，Castillejo JA，et al. Promoter hypermethylation of cancer-related genes：a strong independent prognostic factor in acute lymphoblastic leukemia [J]. Blood，2004，104（8）：2492-2498.
[13] 孙巨勇，牟娜，牟佳，等.PTEN及BCL-2在急性髓系白血病中的表达及意义[J].中国实验血液学杂志，2018， 26（1）：121-125.
[14] Ni J，Xie T，Xiao M，et al. Amide-linked local anesthetics preferentially target leukemia stem cell through inhibition of Wnt/β-catenin [J]. Biochem Biophys Res Commun，2018，503（2）：956-962.
[15] Holyoake TL，Vetrie D. The chronic myeloid leukemia stem cell：stemming the tide of persistence [J]. Blood，2017， 129（12）：1595-1606.
[16] Hales EC，Taub JW，Matherly LH. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis：targeted therapy of gamma-secretase inhibitor resistant T-cell acute lymphoblastic leukemia [J]. Cell Signal，2014， 26（1）：149-161.
[17] Meng F，Henson R，Wehbe-Janek H，et al. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer [J]. Gastroenterology，2007，133（2）：647-658.
[18] 吴共发，黄绮亭，曾宇婷，等.miR-21通过PTEN/AKT通路抑制白血病细胞K562的迁移和增殖[J].医学研究生学报，2013，26（10）：1037-1040.
[19] 臧玉柱，于润红，白炎亮，等.PTEN对急性T淋巴细胞白血病细胞增殖凋亡的影响[J].中国老年学杂志，2018， 38（10）：2446-2449.
[20] Bueso-Ramos CE，Rocha FC，Shishodia S，et al. Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia [J]. Hum Pathol，2004，35（2）：246-253.
[21] Furman RR，Asgary Z，Mascarenhas JO，et al. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells [J]. J Immunol，2000，164（4）：2200-2206.
[22] Yilmaz OH，Valdez R，Theisen BK，et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells [J]. Nature，2006，441（7092）：475-482.
[23] Zhang Y，Gao X，Saucedo LJ，et al. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins [J]. Nat Cell Biol，2003，5（6）：578-581.
[24] Peng C，Chen Y，Yang Z，et al. PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice [J]. Blood，2010，115（3）：626-635.
[25] Huang FF，Wu DS，Zhang L，et al. Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia [J]. Cancer Lett，2013，336（1）：96-105.
2019, Vol. 16 
京公网安备 11010502046598号